Siddharth Sheth

Assistant Professor of Hematology/Oncology

University of North Carolina Hospitals

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Siddharth Sheth is an Assistant Professor of Hematology/Oncology at the University of North Carolina Hospitals. He specializes in the clinical treatment of various cancers, with a focus on head and neck squamous cell carcinoma and thyroid cancer. His recent research encompasses combination therapies, the role of circulating tumor DNA in HPV status determination, and the impact of genomic variations on cancer outcomes.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (2)

Natalia Issaeva

Assistant Profeessor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Jared Weiss

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Siddharth Sheth

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Combination Therapy With Olaparib Plus Lenvatinib in a Patient With BRCA2 -Mutated, Radioiodine-Refractory, Metastatic Papillary Thyroid Cancer: A Case Report

Safety and clinical activity of durvalumab combined with tremelimumab in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase I study

A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma

Circulating tumor HPV DNA as an alternative method to determine HPV status in oropharyngeal squamous cell carcinoma

The Role of Induction Therapy for Sinonasal Cancers

Sinonasal Squamous Cell Carcinoma Survival Outcomes Following Induction Chemotherapy vs Standard of Care Therapy

Mature follow up of induction chemotherapy with carboplatin, nab-paclitaxel, cetuximab in head and neck squamous cell carcinoma

Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate‐risk and high‐risk head and neck squamous cell carcinoma

Correlation of alterations in the KEAP1/CUL3/NFE2L2 pathway with radiation failure in larynx squamous cell carcinoma

Genomic heterogeneity and copy number variant burden are associated with poor recurrence‐free survival and 11q loss in human papillomavirus‐positive squamous cell carcinoma of the oropharynx

Socioeconomic Status Drives Racial Disparities in HPV‐negative Head and Neck Cancer Outcomes

Systematic review and meta‐analysis of racial survival disparities among oropharyngeal cancer cases by HPV status

Collaborators (2)

Natalia Issaeva

Jared Weiss

Make your next move.